Abstract:Cardiovascular diseases, especially hypertension, stand as prominent contributors to global mortality. Hypertension, often referred to as a silent killer syndrome, necessitates the use of multiple medications for effective control and management. A new environmentally friendly HPLC-DAD method is introduced in this study for the concurrent analysis of telmisartan (TEL), chlorthalidone (CHT) and amlodipine besylate (AML), in both pure forms and combined pharmaceutical dosage form. An isocratic elution mode was employed to achieve chromatographic separation, utilizing an Inertsil C18 column (250 × 4.6 mm, 5.0 µm) and a mobile phase mixture of acetonitrile and phosphate buffer (pH 3.0 ± 0.1) with ratio of 35:65, v/v. The separation was achieved within 10 min at a flow rate of 1.0 mL/min. The proposed method's validation was carried out following the guidelines outlined by the International Council for Harmonisation (ICH). The achieved linearity range was 1.0-140.0 μg/mL for TEL and 1.0-100.0 μg/mL for CHT and AML with quantification limits of 0.061, 0.177, and 0.313 μg/mL for TEL, CHT, and AML, respectively. The fixed combination tablet dosage form demonstrated acceptable release profile, as indicated by the in-vitro dissolution studies. The studied dissolution media were phosphate buffer pH 7.5, 0.01 N HCl, and water, utilizing a USP type II apparatus at 37 ± 0.5 °C with a stirring rate of 75 rpm. The proposed method was applied successfully for the quality assessment of Telma-ACT® Tablets with good precision and accuracy. Various tools were used for evaluating the level of greenness, including Green Analytical Procedure Index (GAPI), Analytical Greenness Metric for Sample Preparation (AGREEprep), Analytical Eco-Scale (AES), and Analytical Method Greenness Score (AMGS). These tools had confirmed the eco-friendliness of the proposed method. Additionally, the newly introduced White Analytical Chemistry (WAC), and the Blue Applicability Grade Index (BAGI) have been specifically developed to evaluate the sustainability and the applicability of the method.

Quantification of Captopril using Ultra High Performance Liquid Chromatography

Determination of Contents of Captopril and Hydrochlorothiazide in Compound Captopril Tablets by Ion Chromatography

Determination of Captopril in Human Plasma by High-Performance Liquid Chromatography and Study on the Pharmacokinetics after a Single Oral Dose

High-Throughput Validated Optical Sensor for the Dissolution Studies of Captopril Based on Instrumental-Free Detection through an Overhead Book Scanner

A simple spectrophotometric method for the determination of captopril in pharmaceutical preparations using ammonium molybdate

Fast gradient high performance liquid chromatography method with UV detection for simultaneous determination of seven angiotensin converting enzyme inhibitors together with hydrochlorothiazide in pharmaceutical dosage forms and spiked human plasma and urine.

In Vitro Monitoring of Picogram Levels of Captopril in Human Urine Using Flow Injection Chemiluminescence with Immobilized Reagent Technique

Enhanced Elution of Angiotensin Converting Enzyme Inhibitors in Ion Chromatography: Application to Their Simultaneous Quantitation in Formulations and Human Plasma

Determination of Naproxen in Human Urine by High-Performance Liquid Chromatography with Direct Electrogenerated Chemiluminescence Detection

A Supercritical Fluid Chromatography and Tandem Mass Spectrometry Method for the Simultaneous Quantification of Valsartan and Hydrochlorothiazide in Human Plasma

SUB-MINUTE CAPILLARY ZONE ELECTROPHORESIS METHOD FOR DETERMINATION OF HYDROCHLOROTHIAZIDE IN COMBINATION WITH OTHER ACTIVE INGREDIENTS IN NINE DIFFERENT PHARMACEUTICAL SAMPLES

Novel HPLC Method Validation for Quantification of Dapagliflozin in Bulk Drug and Formulation

Development and Validation of Ultra-Performance Liquid Chromatography (UPLC) Method for Simultaneous Quantification of Hydrochlorothiazide, Amlodipine Besylate, and Valsartan in Marketed Fixed-Dose Combination Tablet

A sustainable HPLC method coupled with diode array detection for versatile quantification of telmisartan, chlorthalidone and amlodipine in a fixed-dose antihypertensive formulation and dissolution studies

Rapid Quantification of Lisinopril in Human Plasma by Liquid Chromatography/tandem Mass Spectrometry

Validated Ultra HPLC Method for the Simultaneous Determination of Atorvastatin, Aspirin, and their Degradation Products in Capsules

Development and Validation of RP-UPLC Method for the Determination of Process and Degradant Impurities Present in Dabigatran Etexilate Mesylate Capsules Using High Strength Silica-T3 Sorbent Column

Separation of Nonivamide and Capsaicin by Ultrahigh-Performance Liquid Chromatography for Routine Analysis of Capsaicinoids in Capsicum Products

Stability-Indicating RP-HPLC Method Development, Qbd Optimization and Validation for assessing Related Impurities in Labetalol Hydrochloride bulk and injectable form

Development and Validation of Chromatographic Methods for Simultaneous Estimation of Aspirin and Pantoprazole Sodium in Pure and Mixture Form

A Quantitative Determination of Fluorochloridone in Rat Plasma by Uplc-Ms/Ms Method: Application to A Pharmacokinetic Study